A randomized, double-blind, placebo-controlled study to assess the safety and tolerability, and efficacy of PBT2 in patients with mild to moderate Huntington disease

  • Churchyard, Andrew, (Primary Chief Investigator (PCI))
  • Stout, Julie (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/03/1230/04/14